April 2013
SJ of Noninfringement Requires Analysis for Direct Infringement and Indirect Infringement Under Akamai Standard
[Appealed from C.D. Cal., Judge King]
Equitable Estoppel May Bar Infringement Claims Against Successors-in-Interest but May Not Bar Infringement Claims for Continuing Patents Without Evidence of Misleading Conduct or Detrimental Reliance
[Appealed from W.D. Wash., Judge Lasnik]
Obviousness-Type Double Patenting Does Not Require Common Ownership or a Complete Identity of Inventors
[Appealed from Board]
SJ of No Indirect Infringement by Gaming Machines Vacated and Remanded Under Akamai
[Appealed from N.D. Cal., Senior Judge Whyte]
Marked Products and Past Payments Under a Licensing Contract May Be Circumstantial Evidence That the Products Are Covered by the License
[Appealed from D.N.J., Judge Wolfson]
Section 24 Subpoenas Are Not Available in Inter Partes Reexamination Proceedings
[Appealed from E.D. Va., Judge Hilton]
Reasonable Reliance on Pretrial Party Admissions Cannot Lead to a Subsequent Finding That a Litigation Is Exceptional Under 35 U.S.C. § 285
[Appealed from E.D. Pa., Judge Tucker]
Conception Not Established by Preliminary Statement About Potential Use and Recommendation for Continued Work
Nos. 12-1214, -1215, -1216, -1217
(Fed. Cir. Mar. 25, 2013)
[Appealed from Board]
Unclaimed Boundary Lines in a Continuation Design Patent Application May Add New Matter Where the Boundary Was Not Suggested in the Disclosure of the Parent Application
[Appealed from Board]
Damages for Overseas Sales Not Established by a Showing of Direct Infringement in the United States and Foreseeability of the Overseas Sales
[Appealed from D. Del., Judge Stark]
Abbreviations | |
ALJ | Administrative Law Judge |
ANDA | Abbreviated New Drug Application |
APA | Administrative Procedures Act |
APJ | Administrative Patent Judge |
Board | Board of Patent Appeals and Interferences |
Commissioner | Commissioner of Patents and Trademarks |
CIP | Continuation-in-Part |
DJ | Declaratory Judgment |
DOE | Doctrine of Equivalents |
FDA | Food and Drug Administration |
IDS | Information Disclosure Statement |
ITC | International Trade Commission |
JMOL | Judgment as a Matter of Law |
MPEP | Manual of Patent Examining Procedure |
NDA | New Drug Application |
PCT | Patent Cooperation Treaty |
PTO | United States Patent and Trademark Office |
SJ | Summary Judgment |
TTAB | Trademark Trial and Appeal Board |